B. Metzler seel. Sohn & Co’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.4M | Buy |
21,335
+1,017
| +5% | +$545K | 0.11% | 97 |
|
2025
Q1 | $8.53M | Buy |
20,318
+5,761
| +40% | +$2.42M | 0.09% | 115 |
|
2024
Q4 | $6.02M | Buy |
14,557
+5,322
| +58% | +$2.2M | 0.06% | 150 |
|
2024
Q3 | $4.67M | Buy |
9,235
+215
| +2% | +$109K | 0.05% | 205 |
|
2024
Q2 | $4.39M | Buy |
9,020
+122
| +1% | +$59.4K | 0.04% | 209 |
|
2024
Q1 | $4.8M | Sell |
8,898
-10,643
| -54% | -$5.75M | 0.05% | 195 |
|
2023
Q4 | $10.8M | Buy |
19,541
+2,796
| +17% | +$1.55M | 0.14% | 90 |
|
2023
Q3 | $7.32M | Buy |
16,745
+1,637
| +11% | +$716K | 0.11% | 112 |
|
2023
Q2 | $7.59M | Buy |
15,108
+10,428
| +223% | +$5.24M | 0.1% | 136 |
|
2023
Q1 | $2.34M | Sell |
4,680
-862
| -16% | -$431K | 0.04% | 267 |
|
2022
Q4 | $2.26M | Sell |
5,542
-1,396
| -20% | -$570K | 0.04% | 261 |
|
2022
Q3 | $2.26M | Sell |
6,938
-3,099
| -31% | -$1.01M | 0.04% | 259 |
|
2022
Q2 | $3.52M | Buy |
10,037
+1,239
| +14% | +$435K | 0.06% | 204 |
|
2022
Q1 | $4.81M | Buy |
8,798
+468
| +6% | +$256K | 0.06% | 190 |
|
2021
Q4 | $5.51M | Buy |
8,330
+3,030
| +57% | +$2M | 0.07% | 175 |
|
2021
Q3 | $3.3M | Sell |
5,300
-97
| -2% | -$60.3K | 0.05% | 229 |
|
2021
Q2 | $3.41M | Buy |
5,397
+153
| +3% | +$96.6K | 0.05% | 213 |
|
2021
Q1 | $2.57M | Buy |
5,244
+89
| +2% | +$43.6K | 0.04% | 249 |
|
2020
Q4 | $2.67M | Buy |
+5,155
| New | +$2.67M | 0.05% | 214 |
|